Showing results (541-550 of 673) with videos related to
Sort By:
Pageof 68
Medical Mycology|November 23, 2023
Development and validation of a colorimetric antifungal susceptibility testing method for the dimorphic fungus Talaromyces marneffeiNguyen Thi Mai Thu, Hannah Borda, Shawin Vitsupakorn, et al.Journal of Medical Microbiology|December 16, 2017
Prevalence, healthcare resource utilization and overall burden of fungal meningitis in the United StatesLefko T Charalambous, Alykhan Premji, Caroline Tybout, et al.Biorxiv : the Preprint Server for Biology|October 3, 2025
In Vitro Evidence to Support Amphotericin B and Flucytosine Combination Therapy for TalaromycosisHeera Natesan Sambath, Shawin Vitsupakorn, Kaushik Sreerama Reddy, et al.Biorxiv : the Preprint Server for Biology|March 30, 2023
Structures of trehalose-6-phosphate synthase, Tps1, from the fungal pathogen <i>Cryptococcus neoformans</i> : a target for novel antifungalsErica J Washington, Ye Zhou, Allen L Hsu, et al.The Lancet. Infectious Diseases|April 19, 2021
Cryptococcal meningoencephalitis: time for actionKatharine Elizabeth Stott, Angela Loyse, Joe N Jarvis, et al.Plos Pathogens|July 30, 2019
Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotypeBenjamin Hommel, Aude Sturny-Leclère, Stevenn Volant, et al.Antimicrobial Agents and Chemotherapy|February 1, 2024
Limitations of antifungal prophylaxis in preventing invasive <i>Candida</i> surgical site infections after liver transplant surgeryM Carugati, S Arif, M E Yarrington, et al.Infection and Immunity|July 26, 2005
Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfectionKirsten Nielsen, Gary M Cox, Anastasia P Litvintseva, et al.Antimicrobial Agents and Chemotherapy|June 19, 2019
Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal MeningoencephalitisLaura L Kovanda, Charles Giamberardino, Laura McEntee, et al.Plos Neglected Tropical Diseases|December 31, 2025
In vitro evidence to support amphotericin B and flucytosine combination therapy for talaromycosisHeera Natesan Sambath, Shawin Vitsupakorn, Kaushik Sreerama Reddy, et al.Pageof 68